Intuitive Surgical reports Q1 2026 earnings on April 21, with focus on tariff impact, procedure growth, and da Vinci 5 system placements. Despite strong 2025 results, the stock is down due to slower 2026 growth guidance and tariff concerns. Investors will watch gross margins, procedure growth rates, and international da Vinci 5 adoption for signs of recovery. A solid Q1 with stable margins and positive guidance could shift sentiment and support stock price rebound.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
